CoChat

Obstructive sleep apnea syndrome in polycystic ovary syndrome: a systematic review and meta-analysis

Open access
Abdul Jafar, Nur K., Al Balushi, Afra, Subramanian, Anuradhaa, Lee, Siang Ing, Bennett, Christie J., Moran, Lisa J., Mousa, Aya, Tay, Chau Thien, Teede, Helena J., Mansfield, Darren R. · 2025 · Frontiers in Endocrinology

The DOI matches its Crossref record; 44 of the 45 references it cites were found in a registry or an index; 47 of the 79 sources its claims cite were checked for support.

Abstract

Background: Polycystic ovary syndrome (PCOS) has been associated with a high prevalence of obstructive sleep apnea syndrome (OSAS). However, the impact of OSAS on the PCOS symptom profile remains unclear. This systematic review and meta-analysis, which informed the 2023 International Evidence-based PCOS Guideline, aims to assess the prevalence and related symptoms of OSAS among females with and without PCOS. Methods: A systematic search using databases (MEDLINE, Embase, EBM Reviews, PsycInfo and CINAHL) was performed until 16 th May 2024. Random-effects restricted maximum likelihood meta-analyses compared OSAS and related symptoms between PCOS and non-PCOS groups. OSAS outcomes were categorized as apnea-hypopnea index (AHI)≥5 only, AHI≥5 with symptoms, AHI≥10 with symptoms and composite OSA (i.e., all AHI cut-offs with and/or without symptoms). Subgroup analyses by body mass index (BMI), age, PCOS diagnostic criteria and ethnicity were performed. Risk of bias and certainty of evidence by the Grading of Recommendations, Assessment, Development and Evaluation (GRADE) framework were conducted. Results: From 4438 records, 3205 titles/abstracts were screened and 40 were eligible for full-text screening. Eight cross-sectional studies met inclusion criteria and meta-analysis. The pooled prevalence of OSA was 37.0% in PCOS (29.0% adolescents; 40.0% adults) and 6.0% in non-PCOS. Compared with non-PCOS, those with PCOS showed higher risk for composite OSA (odds ratio (OR): 9.52; 95% CI: 3.90 to 23.26; I2 = 54.5%; 8 studies, n=942; P<0.001) and more pronounced OSAS risk with increasing symptom severity in PCOS (AHI≥5 OR: 3.90; 95% CI: 1.63 to 9.34; AHI≥5 with symptoms OR: 17.95; 95% CI: 6.17 to 52.22; AHI≥10 with symptoms OR: 30.61; 95% CI: 7.99 to 117.25, all P ≤ 0.0023). Subgroup results showed significantly higher risk of OSAS overall in overweight/obesity, adults and white ethnicity compared with normal weight, adolescent and Asian subgroups, respectively (all P<0.001), but independent of PCOS diagnostic criteria. Conclusion: The prevalence of OSA was higher in PCOS compared with non-PCOS groups, with the risk of OSAS increasing with worse symptom severity. Adults and those of higher BMI and of white ethnicity were at increased risk of OSAS. Hence, identifying and treating OSAS symptoms in PCOS may be beneficial, but further validation of findings is warranted.

Overview

CoChat Summary

TL;DR

This systematic review and meta-analysis found that obstructive sleep apnea (OSA) is substantially more prevalent and more likely in females with polycystic ovary syndrome (PCOS) than in non-PCOS controls, with risk increasing as OSAS symptom severity increases. The findings informed the 2023 International Evidence-based PCOS Guideline and support screening for OSAS symptoms in PCOS, though the authors call for further validation.

Key findings

  • Pooled OSA prevalence was 37.0% in PCOS (29.0% adolescents; 40.0% adults) versus 6.0% in non-PCOS; non-PCOS adolescent and adult prevalence were both 7.0% in the discussion.
  • Composite OSA risk was higher in PCOS: OR 9.52 (95% CI 3.90–23.26; I² = 54.5%; 8 studies, n = 942; P < 0.001).
  • Risk was more pronounced with greater OSAS symptom severity: AHI ≥5 only OR 3.90 (95% CI 1.63–9.34), AHI ≥5 with symptoms OR 17.95 (95% CI 6.17–52.22), and AHI ≥10 with symptoms OR 30.61 (95% CI 7.99–117.25).
  • Subgroup analyses showed significantly higher OSAS risk in overweight/obesity, adults, and white ethnicity compared with normal weight, adolescent, and Asian subgroups, respectively (all P < 0.001), but findings were largely independent of PCOS diagnostic criteria.

Methods

  • Systematic review and meta-analysis registered in PROSPERO and reported per PRISMA; databases MEDLINE, Embase, EBM Reviews, PsycInfo, and CINAHL were searched up to 16 May 2024.
  • Included 8 controlled cross-sectional studies with clinically confirmed PCOS, non-PCOS controls, and formal sleep studies (PSG/polygraph); total participants were 280 with PCOS and 662 without PCOS.
  • Random-effects restricted maximum likelihood meta-analyses compared OSAS outcomes categorized as composite OSA, AHI ≥5 only, AHI ≥5 with symptoms, and AHI ≥10 with symptoms; subgroup analyses examined BMI, age, PCOS diagnostic criteria, and ethnicity, with risk of bias and GRADE assessments.

Limitations

  • Stated by the authors: included studies had moderate to high risk of bias due to detection and selection biases; pooled sample sizes were relatively small; there was variable adjustment for confounders such as age, BMI, and ethnicity; BMI distribution and OSA definitions/assessment methods were heterogeneous; ethnic and geographic groups were under-represented; and single-paper or one-study subgroup analyses should be interpreted cautiously.
  • Evident from the text: all included studies were cross-sectional, with no RCTs identified; publication bias was observed for overall OSA prevalence in both PCOS and non-PCOS populations based on funnel plot asymmetry; GRADE certainty was low for composite OSA and moderate for the other OSAS symptom categories.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.3389/fendo.2025.1532519

Cites

44 of 45 references verified1 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Figure 1 PRISMA flowchart of studies included in the review.
Figure 1 PRISMA flowchart of studies included in the review.CC BY · PubMed Central
Figure 2 Pooled prevalence of OSA (i.e., all AHI cut-offs with and/or without symptoms) in PCOS and non-PCOS populations. (A) PCOS and (B) Non-PCOS.
Figure 2 Pooled prevalence of OSA (i.e., all AHI cut-offs with and/or without symptoms) in PCOS and non-PCOS populations. (A) PCOS and (B) Non-PCOS.CC BY · PubMed Central
Figure 3 Meta-analyses of symptom categories of OSAS in PCOS compared with non-PCOS. (A) Composite OSA, (B) AHI≥5 only, (C) AHI≥5 with symptoms and (D) AHI≥10 with symptoms.
Figure 3 Meta-analyses of symptom categories of OSAS in PCOS compared with non-PCOS. (A) Composite OSA, (B) AHI≥5 only, (C) AHI≥5 with symptoms and (D) AHI≥10 with symptoms.CC BY · PubMed Central
Figure 4 Subgroup analyses of symptom categories of OSAS in PCOS compared with non-PCOS by BMI. (A) Composite OSA, (B) AHI≥5 only and (C) AHI≥5 with symptoms.
Figure 4 Subgroup analyses of symptom categories of OSAS in PCOS compared with non-PCOS by BMI. (A) Composite OSA, (B) AHI≥5 only and (C) AHI≥5 with symptoms.CC BY · PubMed Central
Figure 5 Subgroup analyses of symptom categories of OSAS in PCOS compared with non-PCOS by age. (A) Composite OSA, (B) AHI≥5 only and (C) AHI≥5 with symptoms.
Figure 5 Subgroup analyses of symptom categories of OSAS in PCOS compared with non-PCOS by age. (A) Composite OSA, (B) AHI≥5 only and (C) AHI≥5 with symptoms.CC BY · PubMed Central
Figure 6 Subgroup analyses of symptom categories of OSAS in PCOS compared with non-PCOS by PCOS diagnostic criteria. (A) Composite OSA, (B) AHI≥5 only and (C) AHI≥5 with symptoms.
Figure 6 Subgroup analyses of symptom categories of OSAS in PCOS compared with non-PCOS by PCOS diagnostic criteria. (A) Composite OSA, (B) AHI≥5 only and (C) AHI≥5 with symptoms.CC BY · PubMed Central
Figure 7 Subgroup analyses of symptom categories of OSAS in PCOS compared with non-PCOS by ethnicity. (A) Composite OSA, (B) AHI≥5 only and (C) AHI≥5 with symptoms.
Figure 7 Subgroup analyses of symptom categories of OSAS in PCOS compared with non-PCOS by ethnicity. (A) Composite OSA, (B) AHI≥5 only and (C) AHI≥5 with symptoms.CC BY · PubMed Central

Verification

Claims the paper makes

24 Valid · 3 Not valid · 11 Not checked · 77 Own results and interpretations

70 more claims · 11 with their cited sources checked

Create a free account to see all 115 claims and to verify the 1 reference still open.

See all claims — free account
  • It may state two separate claims as one. 23
  • Probably not a substantial claim. 22

Create a free account to see these claims.

Citations

Cites

Show all 45 references

Research works printed but not linked: 2

  1. Global InfoBase team, 2005, The SuRF Report 2. Surveillance of chronic disease Risk Factors: Country-level data and comparable estimates
  2. 2023, Stata statistical software: release 18. College station

Cited by

See all 15

Metadata

Authors
Abdul Jafar, N. K., Al Balushi, A., Subramanian, A., Lee, S. I., Bennett, C. J., Moran, L. J., Mousa, A., Tay, C. T., Teede, H. J., & Mansfield, D. R.
Affiliations
  • University of Birmingham (GB)
  • Monash University (AU)
  • Monash Medical Centre (AU)
Corresponding author
Mansfield, Darren R.
Venue
Frontiers in Endocrinology
Published
2025-04-04
Volume
16
Pages
1532519-1532519
ISSN
1664-2392 (ISSN-L)
OpenAlex
W4409167502
Cited by
15
References
44
Citations by year
2026: 13 · 2025: 2
FWCI
1.94
Type
journal article
Language
en
Open access
Locations
  • Frontiers in Endocrinology (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Adelaide Research & Scholarship (AR&S) (University of Adelaide) (submittedVersion, cc-by)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • Veski
  • Australian Government
  • Medical Research Council
  • National Health and Medical Research Council (1171592)
Topics
  • Health Sciences › Medicine › Physiology (medical) › Obstructive Sleep Apnea Research
  • Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
  • Social Sciences › Psychology › Experimental and Cognitive Psychology › Sleep and related disorders
Keywords
obstructive sleep apnea, polycystic ovary syndrome, prevalence, apnea-hypopnea index, body mass index, adolescents, adults, ethnicity, PCOS diagnostic criteria, comorbidities, sleep-disordered breathing, insulin resistance, hyperandrogenism
MeSH terms
Female, Humans, Polycystic Ovary Syndrome, Body Mass Index, Prevalence, Sleep Apnea, Obstructive

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Obstructive sleep apnea syndrome in polycystic ovary syndrome: a systematic review and meta-analysis. https://app.cochat.ai/papers/10.3389/fendo.2025.1532519
The paper
Abdul Jafar, N. K., Al Balushi, A., Subramanian, A., Lee, S. I., Bennett, C. J., Moran, L. J., Mousa, A., Tay, C. T., Teede, H. J., & Mansfield, D. R. (2025). Obstructive sleep apnea syndrome in polycystic ovary syndrome: a systematic review and meta-analysis. Frontiers in Endocrinology. https://doi.org/10.3389/fendo.2025.1532519

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.